Rigrodsky & Long, P.A. Announces Investigation Of Astex Pharmaceuticals, Inc. Buyout

Rigrodsky & Long, P.A.:
  • Do you own shares of Astex Pharmaceuticals, Inc. (NASDAQ GS: ASTX )?
  • Did you purchase any of your shares prior to September 5, 2013?
  • Do you think the proposed buyout price is too low?
  • Do you want to discuss your rights?

Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of Astex Pharmaceuticals, Inc. (“Astex” or the “Company”) (NASDAQ GS: ASTX) regarding possible breaches of fiduciary duties and other violations of law related to the Company’s entry into an agreement to be acquired by Otsuka Pharmaceutical Co., Ltd. (“Otsuka”) in a transaction valued at approximately $886 million.

Click here to learn more: http://www.rigrodskylong.com/investigations/astex-pharmaceuticals-inc-astx.

Under the terms of the agreement, public shareholders of Astex will receive $8.50 per share in cash for each share of Astex they own.

The investigation concerns whether Astex’s board of directors failed to adequately shop the Company and obtain the best possible value for Astex’s shareholders before entering into an agreement with Otsuka. According to Yahoo! Finance, at least one analyst has set a price target for Astex stock at $13.00 per share.

If you own the common stock of Astex and purchased your shares before September 5, 2013, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Seth Rigrodsky or Peter Allocco at Rigrodsky & Long, P.A., 825 East Gate Boulevard, Suite 300, Garden City, New York 11530, by telephone at (888) 969-4242; by e-mail to info@rl-legal.com, or at: http://www.rigrodskylong.com/investigations/astex-pharmaceuticals-inc-astx.

Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly prosecutes securities class, derivative and direct actions, shareholder rights litigation and corporate governance litigation, on behalf of shareholders in states and federal courts throughout the United States.

Attorney advertising. Prior results do not guarantee a similar outcome.

If you liked this article you might like

Trade-Ideas: Astex Pharmaceuticals (ASTX) Is Today's Pre-Market Mover With Heavy Volume Stock

Biotech Stock Mailbag: Astex Pharma, My Essential Twitter Follows

Trade-Ideas: Astex Pharmaceuticals (ASTX) Is Today's "Perilous Reversal" Stock

4 Biotech Stocks Under $10 to Trade for Breakouts

Astex Pharmaceuticals Inc Stock Downgraded (ASTX)